Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer Article

Industry Collaboration International Collaboration

cited authors

  • Schiller, Joan H.; von Pawel, Joachim; Schuett, Philipp; Ansari, Rafat H.; Thomas, Michael; Saleh, Mansoor; McCroskey, Robert D.; Pfeifer, Wolfgang; Marsland, Thomas A.; Kloecker, Goetz H.; Sebastian, Martin; Pirker, Robert; Kurek, Raffael; Beadman, Claire; Socinski, Mark A.

authors

Publication Date

  • December 1, 2010

webpage

published in

category

keywords

  • EGFR
  • Humanized monoclonal antibody
  • Matuzumab
  • NSCLC
  • Pemetrexed
  • Second-line

start page

  • 1977

end page

  • 1985

volume

  • 5

issue

  • 12